NEW YORK (GenomeWeb News) — Empire Genomics and BioDiscovery will integrate and co-market certain of their products for the array comparative genomic hybridization market, BioDiscovery said Wednesday. 
 
Empire Genomics, a Buffalo, NY-based start-up, specializes in molecular karyotyping technology in an aCGH platform that is used to quantify “changes in chromosomal abnormalities,” BioDisovery said.
 
BioDiscovery will provide image and aCGH software to the partnership.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.